Management of chylous ascites after liver cirrhosis: A case report

Table 1 Abdominal fluid analysis during different hospitalizations

Date	Color	Transparency	TP (g/L)	ADA (U/L)	Rivalta test	WBC (× 106/L)	LDH (U/L)	Glu (mmol/L)
November 6, 2017	Yellow	Cloudy	22.6	5	Negative	870	10582	19.39
December 25, 2018	Yellow	Cloudy	11.3	3	Negative	244	56	8.44
September 7, 2021	Yellow	Cloudy	15.3	3	Negative	243	83	10.51
February 18, 2022	Yellow	Cloudy	15.7	4	Negative	2137	91	10.08
June 18, 2022	Red	Cloudy	26.3	16	Positive	1233	131	15.79
November 8, 2022	Yellow	Cloudy	16	4	Positive	253	61	13.2
March 14, 2023	Yellow	Cloudy	14.5	2	Negative	82	65	10.65
March 26, 2023	Milky	Cloudy	12.8	2	Negative	184	54	14.34

TP: Total protein; ADA: Adenosine deaminase; WBC: White blood cell; LDH: Lactate dehydrogenase; Glu: Glucose.

Table 2 Variations in liver function during different hospitalizations

Date	TBIL (μmol/L)	ALB (g/L)	PT (seconds)	Ascites	Hepatic encephalopathy	Child-Pugh classification
November 6, 2017	100.1	29	14.7	Mild	No	B
December 25, 2018	20	33	13.6	Severe	No	B
September 7, 2021	83	30.9	19.8	Severe	No	C
February 18, 2022	67.3	25.7	16.5	Severe	No	C
June 18, 2022	81.3	29.6	15.6	Severe	No	C
November 8, 2022	116	31.4	17.8	Severe	No	C
March 14, 2023	50.6	29.5	16.9	Severe	No	C

TBIL: Total bilirubin; ALB: Albumin; PT: Prothrombin time.